Bioprinting & Tissue Engineering Devices Market Report 2025-2033: 3D Bioprinters, Bioinks & Tissue Engineering Growth in United States Expansions

Bioprinting & Tissue Engineering Devices Market size reched US$ 19.42 Billion in 2024 from US$ 17.08 Billion in 2023 and is expected to reach US$ 66.65 Billion by 2033, growing at a CAGR of 14.9% during the forecast period 2025-2033.

DataM Intelligence has released its latest "Bioprinting & Tissue Engineering Devices Market Size 2026" Market research, delivering a data-driven view of market size, revenue, volume, CAGR, regional performance, segment dynamics, and competitive developments. The study examines key growth drivers, emerging opportunities, strategic developments, and evolving industry trends, providing a comprehensive outlook on the market's current landscape and future growth potential.

Download Your Free Sample Report (Get a Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/bioprinting-and-tissue-engineering-devices-market?kb

The Bioprinting & Tissue Engineering Devices Market report provides a comprehensive assessment of market trends, historical growth patterns, technological advancements, and evolving investment dynamics. It highlights recent market developments, emerging growth opportunities, competitive strategies, and expansion plans adopted by key industry participants. The report also evaluates current market dynamics, future growth prospects, and competitive intensity through Porter's Five Forces Analysis.

United States: Recent Industry Developments

✅ July 2026: Auxilium Biotechnologies successfully used its bioprinting platform aboard the International Space Station to produce structures containing human liver, kidney and cartilage cells, highlighting the potential of bioprinting for future tissue manufacturing.

✅ June 2026: Researchers advanced light-based 3D bioprinting technologies, supporting higher-precision fabrication of cell-laden tissue constructs for regenerative medicine and tissue engineering applications.

✅ May 2026: Researchers published new work on DLP bioprinting workflows using methacrylated extracellular matrix materials, strengthening the development of biomimetic bioinks for tissue engineering.

✅ April 2026: U.S.-based tissue engineering research continued to advance printable hydrogel and extracellular-matrix approaches aimed at improving the biological performance and structural fidelity of engineered tissues.

✅ March 2026: Researchers expanded applications of 3D bioprinting for cardiovascular disease models and therapeutic development, demonstrating growing interest in bioprinted tissue platforms for biomedical research.

✅ February 2026: U.S. biomedical research programs continued advancing 3D tissue bioprinting for human-relevant disease models and drug-development applications, building on NIH-supported tissue engineering initiatives.

✅ January 2026: Carnegie Mellon University received up to $28.5 million from ARPA-H to develop a functional 3D bioprinted liver designed to temporarily support patients with acute liver failure and reduce dependence on organ transplantation.

Ready to Grow in the Bioprinting & Tissue Engineering Devices Market? Connect With the Right Partners Today: https://www.datamintelligence.com/partner-identification-enquiry/bioprinting-and-tissue-engineering-devices-market?kb

How We Build Trusted Market Research Reports:

The global Bioprinting & Tissue Engineering Devices Market research report is developed through a structured combination of primary and secondary research methods to deliver reliable and actionable market insights. The study evaluates key factors shaping the market, including regulatory changes, industry trends, competitive dynamics, and historical market performance. It also examines technological advancements, product innovations, and developments across adjacent industries. Furthermore, the report assesses growth opportunities, market risks, operational challenges, and emerging trends that could influence the future development of the global Bioprinting & Tissue Engineering Devices Market.

Future Market Growth Outlook:

The Global Bioprinting & Tissue Engineering Devices Market is expected to witness steady growth during 2026-2033. In 2025 the market maintained consistent growth , supported by increasing strategic initiatives by key players, with this momentum expected to continue throughout the forecast period.

List of the Key Players in the Bioprinting & Tissue Engineering Devices Market:

CELLINK, 3D Systems, Inc., CollPlant Biotechnologies Ltd., Organovo Holdings Inc., Regemat 3D, regenHU, CYFUSE BIOMEDICAL K.K., Poietis Biosystems, and ARTBioprint

Key Market Segmentations 2026:

By application, tissue engineering & regenerative medicine dominated the market in 2024, accounting for the largest revenue share of 34.04%.

By Material: Synthetic Materials, Natural Materials, Scaffolds, and Protein-Based Materials

By Application: Tissue Engineering & Regenerative Medicine, Drug Discovery, Development & Toxicology Testing, Biomedical Research & Academic Applications, Therapeutic Applications, and Others

By End-User: Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, and Contract Manufacturing Organizations

Latest Industry Developments Shaping the Market 2026:

The bioprinting and tissue engineering devices market is advancing through new bioinks, high-resolution bioprinting platforms, tissue models, and collaborations focused on regenerative medicine and drug discovery.

✅ July 2026: Auxilium Biotechnologies achieved a major bioprinting milestone by producing structures containing human liver, kidney, and cartilage cells aboard the International Space Station using its AMP-1 bioprinter, demonstrating the potential of microgravity manufacturing for advanced tissue engineering.

✅ June 2026: CELLINK continued advancing high-resolution bioprinting technologies and tissue engineering applications through its portfolio of extrusion, light-based, and biodispensing bioprinters designed for tissue models, regenerative medicine, and drug discovery.

✅ May 2026: GELITA and Black Drop strengthened collaboration on next-generation bioinks, combining GELITA's hydrogel material expertise with Black Drop's 3D bioprinting capabilities to develop high-performance bioinks for tissue models and implant applications.

✅ April 2026: 3D Systems continued expanding its bioprinting platform, combining bioprinters, biomaterials, bioinks, software, and technical expertise to support tissue engineering, regenerative medicine, and advanced disease models.

✅ March 2026: GELITA partnered with Black Drop to accelerate development of methacrylated gelatin bioinks, targeting improved cell functionality and bioprinting performance for biomedical applications including engineered tissues and implants.

✅ February 2026: CollPlant launched BioFlex, a ready-to-print rhCollagen-based kit optimized for DLP 3D bioprinting, targeting advanced tissue models, drug discovery, engineered tissues, and potential future organ applications.

✅ January 2026: Novo Nordisk expanded its collaboration with Aspect Biosystems to advance cell-based diabetes therapies, with Aspect leveraging its 3D bioprinting technology to create tissue-like structures containing insulin-producing islet cells.

Recent Key Strategic M & A/partnership 2026:

• January 2026: Novo Nordisk expanded its partnership with Aspect Biosystems, including an additional equity investment and transfer of certain cell-therapy technologies and capabilities to Aspect, which uses 3D bioprinting for tissue-like structures.

Buy the Full Market Report Now: https://www.datamintelligence.com/buy-now-page?report=bioprinting-and-tissue-engineering-devices-market?kb

Japan: Recent Industry Developments

✅ July 2026: Japan's regenerative medicine ecosystem continued strengthening tissue-engineering commercialization, with companies advancing cultured-tissue technologies and overseas market expansion.

✅ June 2026: Japan Tissue Engineering Co., Ltd. decided to establish a manufacturing and sales subsidiary in Germany to accelerate the European expansion of its LabCyte human cultured tissue models.

✅ May 2026: Japan Tissue Engineering continued expanding its human tissue-model portfolio and regenerative medicine activities, supporting broader applications of engineered tissue technologies in research and testing.

✅ April 2026: NEDO highlighted CoreTissue BioEngineering's development of a mass-production manufacturing device for tissue-regenerated ligaments and preparations for future U.S. commercialization.

✅ March 2026: Japan Tissue Engineering Co., Ltd. submitted an application for marketing approval of a dried allogeneic cultured epidermis, advancing next-generation engineered tissue products toward commercialization.

✅ February 2026: Japanese regenerative medicine developers continued progressing tissue-engineered products toward scalable manufacturing and clinical applications, supported by national deep-tech commercialization initiatives.

✅ January 2026: CoreTissue BioEngineering was selected under Japan's Deep-Tech Startups Support Program to develop tissue-regenerated ligaments using decellularized biological tissues, including a commercial manufacturing device and U.S. regulatory preparation.

Regional Market Performance:

☞ North America: The region maintains a strong position in the Bioprinting & Tissue Engineering Devices Market, supported by advanced biomedical research, increasing investments in regenerative medicine, and the presence of leading healthcare and biotechnology companies.

☞ Europe: Market growth is driven by expanding tissue engineering research, government-supported healthcare innovation, and increasing adoption of 3D bioprinting technologies in regenerative medicine and pharmaceutical research.

☞ Asia-Pacific: The region is witnessing rapid growth due to rising investments in biotechnology, expanding healthcare infrastructure, and increasing research activities focused on 3D bioprinting, organ regeneration, and personalized medicine.

☞ Latin America: Growing research capabilities and improving healthcare infrastructure are supporting the adoption of bioprinting and tissue engineering technologies, particularly across academic and biomedical research institutions.

☞ Middle East & Africa: Increasing healthcare investments, biotechnology development, and growing interest in advanced regenerative medicine technologies are creating opportunities for bioprinting and tissue engineering devices.

Report Coverage

Chapter 1: Defines the Bioprinting & Tissue Engineering Devices Market scope and presents an executive summary covering key segments by region, type, application, and other relevant categories. It includes market size, growth potential, and development prospects, providing a clear view of current market conditions and expected evolution across short-, medium, and long-term horizons.

Chapter 2: Highlights key market insights, emerging trends, growth patterns, technological developments, and other factors shaping the Bioprinting & Tissue Engineering Devices Market.

Chapter 3: Provides a detailed competitive landscape analysis of Bioprinting & Tissue Engineering Devices manufacturers, including revenue market share, competitive positioning, strategic initiatives, recent developments, mergers, acquisitions, and expansion activities.

Chapter 4: Profiles major companies operating in the Bioprinting & Tissue Engineering Devices Market, covering company overview, product revenue, gross margin, product portfolio, product introductions, recent developments, and strategic activities.

Chapter 5 & 6: Presents regional- and country-level revenue analysis for the Bioprinting & Tissue Engineering Devices Market. It evaluates market size, growth potential, development prospects, market opportunities, and future expansion across major regions and key countries.

Chapter 7: Analyzes the Bioprinting & Tissue Engineering Devices Market by type, examining the market size, growth potential, adoption patterns, and development opportunities across individual market segments.

Chapter 8: Evaluates the Bioprinting & Tissue Engineering Devices Market by application, providing insights into market size, growth potential, demand patterns, and opportunities across major downstream applications.

Chapter 9: Examines the Bioprinting & Tissue Engineering Devices industry value chain, covering key upstream suppliers, manufacturing activities, distribution channels, downstream stakeholders, and the overall flow of value across the industry.

Chapter 10: Summarizes the key findings, market insights, growth opportunities, competitive developments, and major conclusions presented throughout the Bioprinting & Tissue Engineering Devices Market report.

Talk to Our Analyst | Request Customization: https://datamintelligence.com/customize/bioprinting-and-tissue-engineering-devices-market?kb

Market Drivers
• Rising demand for regenerative medicine: Growing use of tissue engineering and bioprinting for repairing or replacing damaged tissues is driving device adoption.

• Advancements in 3D bioprinting: Improved bioinks, printing precision, and multi-material technologies are enabling more complex tissue structures and better research outcomes.

• Increasing organ transplantation demand: Shortages of donor organs are encouraging research into bioprinted tissues and engineered organs as potential alternatives.

• Growing R&D investment: Increased funding from biotechnology companies, research institutes, and healthcare organizations is accelerating development and commercialization of tissue engineering devices.

Frequently Asked Questions (FAQ's):

Q1: What is the current market value of the Bioprinting & Tissue Engineering Devices Market?

A: The Bioprinting & Tissue Engineering Devices Market was valued at US$ 19.42 Billion in 2024 and is projected to reach US$ 66.65 Billion by 2033

Q2: What is the expected growth rate of the Bioprinting & Tissue Engineering Devices Market?

A: The Bioprinting & Tissue Engineering Devices Market is forecast to grow at a CAGR of 14.9% during 2025-2032

Q3: Which region holds the largest share of the Bioprinting & Tissue Engineering Devices Market?

A: North America accounted for the largest share of Bioprinting & Tissue Engineering Devices Market in 2024, contributing 42.87% of total market revenue.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.